EP2069510B1 - Methods for rapidly transforming monocots - Google Patents
Methods for rapidly transforming monocots Download PDFInfo
- Publication number
- EP2069510B1 EP2069510B1 EP07814620.6A EP07814620A EP2069510B1 EP 2069510 B1 EP2069510 B1 EP 2069510B1 EP 07814620 A EP07814620 A EP 07814620A EP 2069510 B1 EP2069510 B1 EP 2069510B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- medium
- explant
- lynx
- growth
- culture medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000000034 method Methods 0.000 title claims abstract description 82
- 230000001131 transforming effect Effects 0.000 title claims description 26
- 241000209510 Liliopsida Species 0.000 title description 6
- 241001057636 Dracaena deremensis Species 0.000 claims abstract description 17
- 239000002609 medium Substances 0.000 claims description 156
- 230000009466 transformation Effects 0.000 claims description 73
- 239000001963 growth medium Substances 0.000 claims description 55
- 229930192334 Auxin Natural products 0.000 claims description 51
- 239000002363 auxin Substances 0.000 claims description 51
- SEOVTRFCIGRIMH-UHFFFAOYSA-N indole-3-acetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CNC2=C1 SEOVTRFCIGRIMH-UHFFFAOYSA-N 0.000 claims description 47
- 230000009261 transgenic effect Effects 0.000 claims description 47
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 46
- 239000004062 cytokinin Substances 0.000 claims description 46
- UQHKFADEQIVWID-UHFFFAOYSA-N cytokinin Natural products C1=NC=2C(NCC=C(CO)C)=NC=NC=2N1C1CC(O)C(CO)O1 UQHKFADEQIVWID-UHFFFAOYSA-N 0.000 claims description 46
- 230000012010 growth Effects 0.000 claims description 42
- 238000011161 development Methods 0.000 claims description 27
- 238000004519 manufacturing process Methods 0.000 claims description 25
- 238000012360 testing method Methods 0.000 claims description 23
- 230000035755 proliferation Effects 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 20
- 230000015572 biosynthetic process Effects 0.000 claims description 18
- 238000012258 culturing Methods 0.000 claims description 17
- 239000003630 growth substance Substances 0.000 claims description 17
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 claims description 15
- 239000005648 plant growth regulator Substances 0.000 claims description 15
- 229930006000 Sucrose Natural products 0.000 claims description 11
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 11
- 239000005720 sucrose Substances 0.000 claims description 11
- 230000000694 effects Effects 0.000 claims description 10
- 239000007787 solid Substances 0.000 claims description 10
- 239000005631 2,4-Dichlorophenoxyacetic acid Substances 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 239000011159 matrix material Substances 0.000 claims description 8
- 230000001404 mediated effect Effects 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 7
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 claims description 6
- 230000000844 anti-bacterial effect Effects 0.000 claims description 5
- 238000009630 liquid culture Methods 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 239000005504 Dicamba Substances 0.000 claims description 4
- IWEDIXLBFLAXBO-UHFFFAOYSA-N dicamba Chemical compound COC1=C(Cl)C=CC(Cl)=C1C(O)=O IWEDIXLBFLAXBO-UHFFFAOYSA-N 0.000 claims description 4
- 230000008635 plant growth Effects 0.000 claims description 4
- 241000589159 Agrobacterium sp. Species 0.000 claims description 3
- 241000589171 Bradyrhizobium sp. Species 0.000 claims description 3
- FAIXYKHYOGVFKA-UHFFFAOYSA-N Kinetin Natural products N=1C=NC=2N=CNC=2C=1N(C)C1=CC=CO1 FAIXYKHYOGVFKA-UHFFFAOYSA-N 0.000 claims description 3
- 241000061177 Mesorhizobium sp. Species 0.000 claims description 3
- 241000589187 Rhizobium sp. Species 0.000 claims description 3
- 241000144249 Sinorhizobium sp. Species 0.000 claims description 3
- QANMHLXAZMSUEX-UHFFFAOYSA-N kinetin Chemical compound N=1C=NC=2N=CNC=2C=1NCC1=CC=CO1 QANMHLXAZMSUEX-UHFFFAOYSA-N 0.000 claims description 3
- 229960001669 kinetin Drugs 0.000 claims description 3
- UZKQTCBAMSWPJD-UQCOIBPSSA-N trans-Zeatin Natural products OCC(/C)=C\CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-UQCOIBPSSA-N 0.000 claims description 3
- UZKQTCBAMSWPJD-FARCUNLSSA-N trans-zeatin Chemical compound OCC(/C)=C/CNC1=NC=NC2=C1N=CN2 UZKQTCBAMSWPJD-FARCUNLSSA-N 0.000 claims description 3
- 229940023877 zeatin Drugs 0.000 claims description 3
- 230000009418 agronomic effect Effects 0.000 claims description 2
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 claims description 2
- 230000002062 proliferating effect Effects 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 abstract description 101
- 230000001172 regenerating effect Effects 0.000 abstract description 2
- 241000721701 Lynx Species 0.000 description 123
- 230000008929 regeneration Effects 0.000 description 50
- 238000011069 regeneration method Methods 0.000 description 50
- 238000012546 transfer Methods 0.000 description 47
- 238000011282 treatment Methods 0.000 description 31
- 230000018109 developmental process Effects 0.000 description 24
- 238000003501 co-culture Methods 0.000 description 22
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 22
- 240000008042 Zea mays Species 0.000 description 21
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 21
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 21
- 235000005822 corn Nutrition 0.000 description 21
- 108090000623 proteins and genes Proteins 0.000 description 17
- 108020004414 DNA Proteins 0.000 description 16
- 230000000408 embryogenic effect Effects 0.000 description 15
- 238000012356 Product development Methods 0.000 description 13
- 238000002474 experimental method Methods 0.000 description 13
- 239000003795 chemical substances by application Substances 0.000 description 12
- 210000002257 embryonic structure Anatomy 0.000 description 9
- 238000011426 transformation method Methods 0.000 description 9
- 241000589158 Agrobacterium Species 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- 229910001961 silver nitrate Inorganic materials 0.000 description 8
- 238000013459 approach Methods 0.000 description 7
- 238000003556 assay Methods 0.000 description 7
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 7
- 229960003669 carbenicillin Drugs 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000005562 Glyphosate Substances 0.000 description 6
- XDDAORKBJWWYJS-UHFFFAOYSA-N glyphosate Chemical compound OC(=O)CNCP(O)(O)=O XDDAORKBJWWYJS-UHFFFAOYSA-N 0.000 description 6
- 229940097068 glyphosate Drugs 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 241000209094 Oryza Species 0.000 description 5
- 235000007164 Oryza sativa Nutrition 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 239000012877 elongation medium Substances 0.000 description 5
- 239000012092 media component Substances 0.000 description 5
- 235000009566 rice Nutrition 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 5
- 102000007469 Actins Human genes 0.000 description 4
- 108010085238 Actins Proteins 0.000 description 4
- OJOBTAOGJIWAGB-UHFFFAOYSA-N acetosyringone Chemical compound COC1=CC(C(C)=O)=CC(OC)=C1O OJOBTAOGJIWAGB-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- -1 BAP) Natural products 0.000 description 3
- 241000701489 Cauliflower mosaic virus Species 0.000 description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 3
- HFCYZXMHUIHAQI-UHFFFAOYSA-N Thidiazuron Chemical compound C=1C=CC=CC=1NC(=O)NC1=CN=NS1 HFCYZXMHUIHAQI-UHFFFAOYSA-N 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000013401 experimental design Methods 0.000 description 3
- 210000001161 mammalian embryo Anatomy 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 230000010152 pollination Effects 0.000 description 3
- 230000010076 replication Effects 0.000 description 3
- 238000004904 shortening Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000003104 tissue culture media Substances 0.000 description 3
- 229920000936 Agarose Polymers 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000012881 co-culture medium Substances 0.000 description 2
- 238000012136 culture method Methods 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 239000004009 herbicide Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 108010058731 nopaline synthase Proteins 0.000 description 2
- 230000008121 plant development Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012882 rooting medium Substances 0.000 description 2
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 2
- 229960000268 spectinomycin Drugs 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- VKTCMMONRNFKJD-BYPYZUCNSA-N (2r)-3-aminosulfanyl-2-(ethylamino)propanoic acid Chemical compound CCN[C@H](C(O)=O)CSN VKTCMMONRNFKJD-BYPYZUCNSA-N 0.000 description 1
- RBMGJIZCEWRQES-DKWTVANSSA-N (2s)-2,4-diamino-4-oxobutanoic acid;hydrate Chemical compound O.OC(=O)[C@@H](N)CC(N)=O RBMGJIZCEWRQES-DKWTVANSSA-N 0.000 description 1
- FPJGLSZLQLNZIW-VIFPVBQESA-N (2s)-2-amino-3-(4-methyl-1h-indol-3-yl)propanoic acid Chemical compound CC1=CC=CC2=C1C(C[C@H](N)C(O)=O)=CN2 FPJGLSZLQLNZIW-VIFPVBQESA-N 0.000 description 1
- VRYALKFFQXWPIH-PBXRRBTRSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-PBXRRBTRSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 239000002794 2,4-DB Substances 0.000 description 1
- YIVXMZJTEQBPQO-UHFFFAOYSA-N 2,4-DB Chemical compound OC(=O)CCCOC1=CC=C(Cl)C=C1Cl YIVXMZJTEQBPQO-UHFFFAOYSA-N 0.000 description 1
- QRBLKGHRWFGINE-UGWAGOLRSA-N 2-[2-[2-[[2-[[4-[[2-[[6-amino-2-[3-amino-1-[(2,3-diamino-3-oxopropyl)amino]-3-oxopropyl]-5-methylpyrimidine-4-carbonyl]amino]-3-[(2r,3s,4s,5s,6s)-3-[(2s,3r,4r,5s)-4-carbamoyl-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)- Chemical compound N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(C)=O)NC(=O)C(C)C(O)C(C)NC(=O)C(C(O[C@H]1[C@@]([C@@H](O)[C@H](O)[C@H](CO)O1)(C)O[C@H]1[C@@H]([C@](O)([C@@H](O)C(CO)O1)C(N)=O)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C QRBLKGHRWFGINE-UGWAGOLRSA-N 0.000 description 1
- IAJOBQBIJHVGMQ-UHFFFAOYSA-N 2-amino-4-[hydroxy(methyl)phosphoryl]butanoic acid Chemical compound CP(O)(=O)CCC(N)C(O)=O IAJOBQBIJHVGMQ-UHFFFAOYSA-N 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- 108010000700 Acetolactate synthase Proteins 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 108010006654 Bleomycin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 108091026890 Coding region Proteins 0.000 description 1
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000005561 Glufosinate Substances 0.000 description 1
- 229940127553 Hydroxyphenylpyruvate Dioxygenase Inhibitors Drugs 0.000 description 1
- GRRNUXAQVGOGFE-UHFFFAOYSA-N Hygromycin-B Natural products OC1C(NC)CC(N)C(O)C1OC1C2OC3(C(C(O)C(O)C(C(N)CO)O3)O)OC2C(O)C(CO)O1 GRRNUXAQVGOGFE-UHFFFAOYSA-N 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
- 239000005574 MCPA Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 238000000636 Northern blotting Methods 0.000 description 1
- UOZODPSAJZTQNH-UHFFFAOYSA-N Paromomycin II Natural products NC1C(O)C(O)C(CN)OC1OC1C(O)C(OC2C(C(N)CC(N)C2O)OC2C(C(O)C(O)C(CO)O2)N)OC1CO UOZODPSAJZTQNH-UHFFFAOYSA-N 0.000 description 1
- LTQCLFMNABRKSH-UHFFFAOYSA-N Phleomycin Natural products N=1C(C=2SC=C(N=2)C(N)=O)CSC=1CCNC(=O)C(C(O)C)NC(=O)C(C)C(O)C(C)NC(=O)C(C(OC1C(C(O)C(O)C(CO)O1)OC1C(C(OC(N)=O)C(O)C(CO)O1)O)C=1NC=NC=1)NC(=O)C1=NC(C(CC(N)=O)NCC(N)C(N)=O)=NC(N)=C1C LTQCLFMNABRKSH-UHFFFAOYSA-N 0.000 description 1
- 108010035235 Phleomycins Proteins 0.000 description 1
- 108020001991 Protoporphyrinogen Oxidase Proteins 0.000 description 1
- 102000005135 Protoporphyrinogen oxidase Human genes 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 229930189330 Streptothricin Natural products 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- WHKUVVPPKQRRBV-UHFFFAOYSA-N Trasan Chemical compound CC1=CC(Cl)=CC=C1OCC(O)=O WHKUVVPPKQRRBV-UHFFFAOYSA-N 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 101150067314 aadA gene Proteins 0.000 description 1
- HLVPIMVSSMJFPS-UHFFFAOYSA-N abscisic acid beta-D-glucopyranosyl ester Natural products O1C(CO)C(O)C(O)C(O)C1OC(=O)C=C(C)C=CC1(O)C(C)=CC(=O)CC1(C)C HLVPIMVSSMJFPS-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
- 229950006790 adenosine phosphate Drugs 0.000 description 1
- 108010050516 adenylate isopentenyltransferase Proteins 0.000 description 1
- PMMURAAUARKVCB-UHFFFAOYSA-N alpha-D-ara-dHexp Natural products OCC1OC(O)CC(O)C1O PMMURAAUARKVCB-UHFFFAOYSA-N 0.000 description 1
- 229940033655 asparagine monohydrate Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- SXKNCCSPZDCRFD-UHFFFAOYSA-N betaine aldehyde Chemical compound C[N+](C)(C)CC=O SXKNCCSPZDCRFD-UHFFFAOYSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 229960001561 bleomycin Drugs 0.000 description 1
- OYVAGSVQBOHSSS-UAPAGMARSA-O bleomycin A2 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC=C(N=1)C=1SC=C(N=1)C(=O)NCCC[S+](C)C)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C OYVAGSVQBOHSSS-UAPAGMARSA-O 0.000 description 1
- FAPWYRCQGJNNSJ-CTWWJBIBSA-L calcium;3-[[(2s)-2,4-dihydroxy-3,3-dimethylbutanoyl]amino]propanoate Chemical compound [Ca+2].OCC(C)(C)[C@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-CTWWJBIBSA-L 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 230000010307 cell transformation Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229960005091 chloramphenicol Drugs 0.000 description 1
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000009795 derivation Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000012737 fresh medium Substances 0.000 description 1
- BRZYSWJRSDMWLG-CAXSIQPQSA-N geneticin Natural products O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](C(C)O)O2)N)[C@@H](N)C[C@H]1N BRZYSWJRSDMWLG-CAXSIQPQSA-N 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 101150054900 gus gene Proteins 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- GRRNUXAQVGOGFE-NZSRVPFOSA-N hygromycin B Chemical compound O[C@@H]1[C@@H](NC)C[C@@H](N)[C@H](O)[C@H]1O[C@H]1[C@H]2O[C@@]3([C@@H]([C@@H](O)[C@@H](O)[C@@H](C(N)CO)O3)O)O[C@H]2[C@@H](O)[C@@H](CO)O1 GRRNUXAQVGOGFE-NZSRVPFOSA-N 0.000 description 1
- 229940097277 hygromycin b Drugs 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000012499 inoculation medium Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 239000012577 media supplement Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 230000000442 meristematic effect Effects 0.000 description 1
- 229960000485 methotrexate Drugs 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- UOZODPSAJZTQNH-LSWIJEOBSA-N paromomycin Chemical compound N[C@@H]1[C@@H](O)[C@H](O)[C@H](CN)O[C@@H]1O[C@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](N)C[C@@H](N)[C@@H]2O)O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)N)O[C@@H]1CO UOZODPSAJZTQNH-LSWIJEOBSA-N 0.000 description 1
- 238000004161 plant tissue culture Methods 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000979 retarding effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- NRAUADCLPJTGSF-VLSXYIQESA-N streptothricin F Chemical compound NCCC[C@H](N)CC(=O)N[C@@H]1[C@H](O)[C@@H](OC(N)=O)[C@@H](CO)O[C@H]1\N=C/1N[C@H](C(=O)NC[C@H]2O)[C@@H]2N\1 NRAUADCLPJTGSF-VLSXYIQESA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 230000025366 tissue development Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000005030 transcription termination Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 244000045561 useful plants Species 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
- C12N15/8205—Agrobacterium mediated transformation
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H1/00—Processes for modifying genotypes ; Plants characterised by associated natural traits
- A01H1/04—Processes of selection involving genotypic or phenotypic markers; Methods of using phenotypic markers for selection
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H4/00—Plant reproduction by tissue culture techniques ; Tissue culture techniques therefor
- A01H4/001—Culture apparatus for tissue culture
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01H—NEW PLANTS OR NON-TRANSGENIC PROCESSES FOR OBTAINING THEM; PLANT REPRODUCTION BY TISSUE CULTURE TECHNIQUES
- A01H6/00—Angiosperms, i.e. flowering plants, characterised by their botanic taxonomy
- A01H6/46—Gramineae or Poaceae, e.g. ryegrass, rice, wheat or maize
- A01H6/4684—Zea mays [maize]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
- C12N15/821—Non-antibiotic resistance markers, e.g. morphogenetic, metabolic markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
- C12N15/821—Non-antibiotic resistance markers, e.g. morphogenetic, metabolic markers
- C12N15/8212—Colour markers, e.g. beta-glucoronidase [GUS], green fluorescent protein [GFP], carotenoid
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8262—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
- C12N15/8265—Transgene containment, e.g. gene dispersal
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/686—Polymerase chain reaction [PCR]
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Definitions
- embryogenic culture responses of different breeding lines differ greatly, limiting the genotypes of crops such as corn that can be transformed. Accordingly, some lines can form embryogenic callus readily, although many, in general, fail to form any embryogenic callus. Such lines are often considered “recalcitrant" lines. This can require use of non-elite lines for transformation, which can require many generations of breeding to produce agronomically-elite transgenic varieties. Thus there is further a need for transformation methods that allow transformation of hitherto "recalcitrant" corn genotypes to allow a wider choice of transformable lines for product development, as well as for screening such genotypes for their potential transformability.
- the first culture medium comprises 0.001 mg/L to 10mg/L of cytokinin and 0.1 mg to 15 mg/L auxin, for instance 0.005 mg/L cytokinin to 0.05 mg/L cytokinin, and 0.1 mg/L auxin or 0.2 mg/L auxin to 0.5 mg/L auxin.
- the explant is further cultured on a fourth medium between culturing on the first and the second medium, wherein the fourth medium comprises an effective amount of auxin and cytokinin to promote callus proliferation.
- the fourth medium is Lynx 2063.
- the invention provides improved transformation methods that substantially reduce the time required for production of transgenic corn plants and expands the range of genotypes that can be transformed.
- use of liquid media combined with efficient plant-handling procedures and simplified media, and culture steps offers advantages such as shorter production time, higher through-put, lower material and labor costs, and ergonomic safety benefits, while maintaining transformation frequency (TF) at a useful level, or even improving TF.
- TF transformation frequency
- methods for assessing the transformability of cells of a corn plant line have typically focused on measuring the ability of a given line to produce embryogenic callus under the right conditions.
- These conventional approaches for screening for embryogenic callus formation utilize immature embryos that are isolated and grown on tissue culture media capable of supporting embryogenic callus formation.
- Just as important for transformability is the ability of a cell line to sustain such embryogenic callus growth over time, since some cell lines display a brief burst of callus formation, but do not subsequently maintain their embryogenic potential.
- This example describes the making of the DNA constructs and transformation of the DNA constructs into ABI Agrobacterium strain (a disarmed C58 strain) used for transformation of corn immature embryos.
- the plasmid pMON 97367 contains a cp4 gene as the selectable marker and a gus gene as the screenable marker driven by the chimeric rice actin and rice actin promoter, respectively.
- Strains of Agrobacterium were prepared for transformation essentially according to procedures described elsewhere, such as Cai et a/. (U.S. Patent Applic. Publn. 2004/00244075 ).
- This example describes a transformation method, including regeneration steps ( FIG. 1 , "Rapid Transformation” scheme, bottom diagram), by which is obtained, after about as little as 6 weeks of growth, a regenerated plant in a solid growth medium (e.g. growth plug).
- IEs immature embryos
- This example demonstrates production of transgenic plants within 7 and 6 weeks by decreasing the time spent on Lynx 2063 by 1 week and thus limiting callus proliferation.
- the outline of the experiment and results are shown in Table 6.
- the results suggest that a reduced callusing phase can be used without affecting TF.
- the results also suggested that a further reduction or elimination in callusing phase may be possible which may speed-up the process of transgenic plant production.
- Table 6 Production of transgenic plants within 7 or 6 weeks by reducing the callusing phase.
- % TF is the mean of at least 3 independent experiments and is based on % independent transgenic plant events.
- This example illustrates the role of appropriate cell proliferation of explants during co-culture and delay medium (the first medium) on TF.
- the callus growth of the explants was controlled by the level of 2,4-D in the co-culture /delay medium.
- Table 8 the effect of one week culture on the 1st medium (e.g., 2232, 1947, 2233 or 1898; Table 2) was tested, followed by a six week transformation protocol. It is evident from the results that amount of callusing during co-culture /delay before regeneration determines TF.
- An auxin level at a lower concentration i.e. 0.2mg/L in Lynx 2232 had zero TF while explants cultured on 1947 having 0.5 mg/L gave a TF of about 35%.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Developmental Biology & Embryology (AREA)
- Botany (AREA)
- Environmental Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Physiology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Mycology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Compounds Of Unknown Constitution (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84151906P | 2006-08-31 | 2006-08-31 | |
PCT/US2007/077366 WO2008028119A2 (en) | 2006-08-31 | 2007-08-31 | Methods for rapidly transforming monocots |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2069510A2 EP2069510A2 (en) | 2009-06-17 |
EP2069510B1 true EP2069510B1 (en) | 2013-07-24 |
Family
ID=38779916
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07841704.5A Active EP2054517B1 (en) | 2006-08-31 | 2007-08-31 | Plant transformation without selection |
EP11174892.7A Active EP2390337B1 (en) | 2006-08-31 | 2007-08-31 | Plant transformation without selection |
EP07814616A Active EP2057272B1 (en) | 2006-08-31 | 2007-08-31 | Methods for producing transgenic plants |
EP07814620.6A Active EP2069510B1 (en) | 2006-08-31 | 2007-08-31 | Methods for rapidly transforming monocots |
EP17188292.1A Ceased EP3269818A1 (en) | 2006-08-31 | 2007-08-31 | Plant transformation without selection |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07841704.5A Active EP2054517B1 (en) | 2006-08-31 | 2007-08-31 | Plant transformation without selection |
EP11174892.7A Active EP2390337B1 (en) | 2006-08-31 | 2007-08-31 | Plant transformation without selection |
EP07814616A Active EP2057272B1 (en) | 2006-08-31 | 2007-08-31 | Methods for producing transgenic plants |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17188292.1A Ceased EP3269818A1 (en) | 2006-08-31 | 2007-08-31 | Plant transformation without selection |
Country Status (12)
Country | Link |
---|---|
US (16) | US8124411B2 (es) |
EP (5) | EP2054517B1 (es) |
JP (3) | JP5329412B2 (es) |
CN (5) | CN101528933B (es) |
AT (1) | ATE497008T1 (es) |
AU (3) | AU2007289105B2 (es) |
BR (4) | BRPI0716373B1 (es) |
CA (8) | CA2884046C (es) |
DE (1) | DE602007012269D1 (es) |
MX (3) | MX2009002250A (es) |
WO (3) | WO2008028119A2 (es) |
ZA (3) | ZA200901140B (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040210958A1 (en) * | 2003-03-19 | 2004-10-21 | Monsanto Technology Llc | A Novel Culture Method for Corn Transformation |
US7682829B2 (en) * | 2003-05-30 | 2010-03-23 | Monsanto Technology Llc | Methods for corn transformation |
JP4525314B2 (ja) * | 2004-11-26 | 2010-08-18 | 沖電気工業株式会社 | 光符号分割多重送受信方法及び光符号分割多重送受信装置 |
US8124411B2 (en) | 2006-08-31 | 2012-02-28 | Monsanto Technology Llc | Methods for producing transgenic plants |
WO2009029852A2 (en) | 2007-08-31 | 2009-03-05 | Monsanto Technology Llc | Method and apparatus for substantially isolating plant tissues |
JP2011120478A (ja) * | 2008-03-31 | 2011-06-23 | Japan Tobacco Inc | アグロバクテリウム菌による形質転換植物の作成方法 |
US8952219B2 (en) | 2009-06-25 | 2015-02-10 | Syngenta Participations Ag | Methods for Agrobacterium-mediated transformation of sugar cane |
CA2773281C (en) | 2009-09-11 | 2020-01-07 | Imperial Innovations Limited | Method of producing leafy biomass from undifferentiated plant cells, and related method for polypeptide production |
CN102958348A (zh) | 2010-06-24 | 2013-03-06 | 先正达参股股份有限公司 | 用于农杆菌介导的甘蔗转化的方法 |
BR112013015247B1 (pt) | 2010-12-17 | 2021-11-23 | Monsanto Technology Llc | Método para melhorar a competência de células de milho para transformação mediada por bactérias |
US20130091606A1 (en) * | 2011-06-24 | 2013-04-11 | Bayer Cropscience Lp | Methods and compositions for enhanced Agrobacterium-mediated transformation Efficiency |
US11807846B2 (en) * | 2012-04-29 | 2023-11-07 | Monsanto Technology Llc | Methods for transforming corn explants |
US11713465B2 (en) | 2013-11-21 | 2023-08-01 | Monsanto Technology, Llc | Methods for transforming wheat explants and compositions therefor |
DE102013020605A1 (de) | 2013-12-15 | 2015-06-18 | Kws Saat Ag | Selektionsmarker-freies rhizobiaceae-vermitteltes verfahren zur herstellung einer transgenen pflanze der gattung triticum |
CN103766221B (zh) * | 2014-02-10 | 2016-08-17 | 中国农业大学 | 一种单子叶植物的组织培养方法 |
CA2937828C (en) | 2014-03-07 | 2020-07-21 | Pioneer Hi-Bred International, Inc. | Methods and systems for extracting monocot embryos |
GB2533129A (en) * | 2014-12-11 | 2016-06-15 | Alkion Biopharma Sas | Bioreactor |
WO2016105185A1 (en) * | 2014-12-22 | 2016-06-30 | Keygene N.V. | Plant callus populations |
CN107683189A (zh) * | 2015-06-29 | 2018-02-09 | 美国陶氏益农公司 | 用于自动化的外植体制备的系统及使用方法 |
JP6716876B2 (ja) * | 2015-09-14 | 2020-07-01 | 住友ゴム工業株式会社 | 遺伝的に改変された植物体を作製するための形質転換植物体の製造方法、及びこの製造方法により作製された、遺伝的に改変された形質転換植物体 |
CN108368517B (zh) * | 2015-10-30 | 2022-08-02 | 先锋国际良种公司 | 用于快速植物转化的方法和组合物 |
CN105660422B (zh) * | 2016-04-20 | 2017-09-29 | 遵义医学院 | 一种白及种苗的组织培养方法 |
EP3400962A1 (en) | 2017-05-09 | 2018-11-14 | Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. | Inhibitors of il-38 for use in treating and/or preventing cancer in a subject |
KR20200015629A (ko) * | 2017-06-02 | 2020-02-12 | 프라운호퍼-게젤샤프트 추르 푀르데룽 데어 안제반텐 포르슝 에 파우 | 식물 세포 팩의 자동 형질전환 방법 |
CN110226517B (zh) * | 2019-06-26 | 2021-06-01 | 北京市农林科学院 | 一种洋葱离体再生的方法及其使用的培养基 |
CN110607323A (zh) * | 2019-09-24 | 2019-12-24 | 四川育良生物科技有限公司 | 一种农杆菌介导水稻遗传转化方法 |
WO2023049903A1 (en) * | 2021-09-27 | 2023-03-30 | Monsanto Technology Llc | Compositions and methods for transformation of monocot seed excised embryo explants |
WO2023049893A1 (en) * | 2021-09-27 | 2023-03-30 | Monsanto Technology Llc | Compositions and methods for transformation of monocot seed excised embryo explants |
WO2023049901A1 (en) * | 2021-09-27 | 2023-03-30 | Monsanto Technology Llc | Compositions and methods for transformation of monocot seed excised embryo explants |
CN118510388A (zh) * | 2021-12-22 | 2024-08-16 | 巴斯夫农业种子解决方案美国有限责任公司 | 改进的用于基因组编辑事件的筛选方法 |
AR128429A1 (es) * | 2022-02-03 | 2024-05-08 | Corteva Agriscience Llc | Preparación de explantes foliares de monocotiledóneas |
Family Cites Families (108)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1470850A (en) | 1972-12-01 | 1977-04-21 | Allied Chem | Moulding poder |
US3847888A (en) | 1972-12-01 | 1974-11-12 | Allied Chem | Ultra-high molecular weight polyethylene molding powder and molding process |
EP0090033A1 (en) | 1981-10-01 | 1983-10-05 | International Plant Research Institute | Process for the genetic modification of cereals with transformation vectors |
US4535060A (en) | 1983-01-05 | 1985-08-13 | Calgene, Inc. | Inhibition resistant 5-enolpyruvyl-3-phosphoshikimate synthetase, production and use |
US5352605A (en) | 1983-01-17 | 1994-10-04 | Monsanto Company | Chimeric genes for transforming plant cells using viral promoters |
US4757011A (en) | 1983-09-30 | 1988-07-12 | E. I. Du Pont De Nemours And Company | Herbicide resistant tobacco |
WO1985001856A1 (en) | 1983-11-03 | 1985-05-09 | Johannes Martenis Jacob De Wet | Method for the transfer of exogenous genes in plants using pollen as a vector |
DE3405185C2 (de) | 1984-02-14 | 1987-02-26 | Plüss-Staufer AG, Oftringen, Aargau | Vorrichtung zur Herstellung von Kompaktlingen aus Polymeren und Additiven |
EP0175769B1 (en) | 1984-03-29 | 1990-10-31 | Hoechst Celanese Corporation | Polyethylene molding composition and process |
NL8401048A (nl) | 1984-04-03 | 1985-11-01 | Rijksuniversiteit Leiden En Pr | Werkwijze voor het inbouwen van vreemd dna in het genoom van eenzaadlobbige planten. |
ATE204017T1 (de) | 1984-05-11 | 2001-08-15 | Syngenta Participations Ag | Transformation von pflanzenerbgut |
US4940835A (en) | 1985-10-29 | 1990-07-10 | Monsanto Company | Glyphosate-resistant plants |
US5107065A (en) | 1986-03-28 | 1992-04-21 | Calgene, Inc. | Anti-sense regulation of gene expression in plant cells |
US5177010A (en) | 1986-06-30 | 1993-01-05 | University Of Toledo | Process for transforming corn and the products thereof |
US5004863B2 (en) | 1986-12-03 | 2000-10-17 | Agracetus | Genetic engineering of cotton plants and lines |
US4971908A (en) | 1987-05-26 | 1990-11-20 | Monsanto Company | Glyphosate-tolerant 5-enolpyruvyl-3-phosphoshikimate synthase |
DE68923728T2 (de) | 1988-04-25 | 1996-02-22 | Monsanto Co | Insektenresistente Salatpflanzen. |
EP0419533A1 (en) | 1988-06-01 | 1991-04-03 | THE TEXAS A&M UNIVERSITY SYSTEM | Method for transforming plants via the shoot apex |
US5990387A (en) | 1988-06-10 | 1999-11-23 | Pioneer Hi-Bred International, Inc. | Stable transformation of plant cells |
US5416011A (en) | 1988-07-22 | 1995-05-16 | Monsanto Company | Method for soybean transformation and regeneration |
ES2164633T3 (es) | 1989-02-24 | 2002-03-01 | Monsanto Technology Llc | Genes vegetales sinteticos y procedimiento para su preparacion. |
HU218717B (hu) * | 1989-03-17 | 2000-11-28 | E. I. Du Pont De Nemours And Co. | Nukleinsav-termelést fokozó növényi eredetű génfragmentek és eljárás előállításukra |
US5106739A (en) | 1989-04-18 | 1992-04-21 | Calgene, Inc. | CaMv 355 enhanced mannopine synthase promoter and method for using same |
US7705215B1 (en) | 1990-04-17 | 2010-04-27 | Dekalb Genetics Corporation | Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof |
US5641876A (en) | 1990-01-05 | 1997-06-24 | Cornell Research Foundation, Inc. | Rice actin gene and promoter |
US5484956A (en) | 1990-01-22 | 1996-01-16 | Dekalb Genetics Corporation | Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin |
US5225341A (en) | 1990-07-19 | 1993-07-06 | The Regents Of The University Of California | Biologically safe plant transformation system using a ds transposon |
CA2096843C (en) * | 1990-11-23 | 2007-08-07 | Kathleen D'halluin | Process for transforming monocotyledonous plants |
US5484620A (en) | 1990-12-22 | 1996-01-16 | Schenk-Filterbau Gesellschaft Mit Beschrankter Haftung | Method of manufacturing stabilizing and/or filtering aids for use in the processing of liquids, especially beverages |
AU662202B2 (en) | 1992-02-24 | 1995-08-24 | Montell North America Inc. | Polyolefin compositions having good transparency and impact resistance |
DE4210351A1 (de) | 1992-03-30 | 1993-10-07 | Hoechst Ag | Verfahren zum Pelletieren von ultrahochmolekularem Polyethylen |
DE4211529A1 (de) | 1992-04-06 | 1993-10-07 | Herding Entstaubung | Filterelement mit einem formstabilen, durchlässig-porösen Kunststoff-Formkörper |
US5591616A (en) | 1992-07-07 | 1997-01-07 | Japan Tobacco, Inc. | Method for transforming monocotyledons |
WO1994002620A2 (en) | 1992-07-27 | 1994-02-03 | Pioneer Hi-Bred International, Inc. | An improved method of agrobacterium-mediated transformation of cultured soybean cells |
GB9321557D0 (en) * | 1992-11-03 | 1993-12-08 | Zeneca Ltd | Carboxamide derivatives |
FI933682A0 (fi) * | 1993-08-20 | 1993-08-20 | Valtion Teknillinen | Metod foer att producera transgena saedesvaexter |
US6326527B1 (en) | 1993-08-25 | 2001-12-04 | Dekalb Genetics Corporation | Method for altering the nutritional content of plant seed |
US5362865A (en) | 1993-09-02 | 1994-11-08 | Monsanto Company | Enhanced expression in plants using non-translated leader sequences |
WO1995006722A1 (fr) * | 1993-09-03 | 1995-03-09 | Japan Tobacco Inc. | Procede permettant de transformer une monocotyledone avec un scutellum d'embryon immature |
JP3102888B2 (ja) | 1993-12-08 | 2000-10-23 | 日本たばこ産業株式会社 | 植物の形質転換方法及びそのためのベクター |
US5750870A (en) | 1994-06-17 | 1998-05-12 | Agritope, Inc. | Plant genetic transformation methods and transgenic plants |
US5767368A (en) | 1995-04-03 | 1998-06-16 | Board Of Trustees Operating Michigan State University | Method for producting a cereal plant with foreign DNA |
DE19517465C1 (de) * | 1995-05-12 | 1997-01-23 | Degussa | Percarbonsäurelösungen mit verbesserter Stabilität im Kontakt mit Edelstahl |
AR006928A1 (es) * | 1996-05-01 | 1999-09-29 | Pioneer Hi Bred Int | Una molecula de adn aislada que codifica una proteina fluorescente verde como marcador rastreable para la transformacion de plantas, un metodo para laproduccion de plantas transgenicas, un vector de expresion, una planta transgenica y celulas de dichas plantas. |
HUP9902123A3 (en) | 1996-06-21 | 2002-01-28 | Monsanto Technology Llc St Louis | Methods for the production of stably-transformed, fertile wheat employing agrobacterium-mediated transformation |
CN1206435A (zh) | 1996-10-22 | 1999-01-27 | 日本烟草产业株式会社 | 印度水稻的转化方法 |
JPH10117776A (ja) | 1996-10-22 | 1998-05-12 | Japan Tobacco Inc | インディカイネの形質転換方法 |
US5919999A (en) | 1996-11-14 | 1999-07-06 | Queen's University At Kingston | Enhanced transport with a plastid membrane transport protein |
US6002068A (en) * | 1996-12-19 | 1999-12-14 | Novartis Finance Corporation | Methods for conferring insect resistance to a monocot using a perioxidase coding sequence |
US5981840A (en) * | 1997-01-24 | 1999-11-09 | Pioneer Hi-Bred International, Inc. | Methods for agrobacterium-mediated transformation |
AU7479298A (en) * | 1997-05-16 | 1998-12-08 | Pioneer Hi-Bred International, Inc. | Recovery of transformed plants without selectable markers by nodal culture and enrichment of transgenic sectors |
GB9710475D0 (en) | 1997-05-21 | 1997-07-16 | Zeneca Ltd | Gene silencing |
US6140555A (en) * | 1997-06-06 | 2000-10-31 | Mississippi State University | Methods for maize transformation coupled with adventitious regeneration utilizing nodal section explants and mature zygotic embryos |
FI104907B (fi) | 1997-09-18 | 2000-04-28 | Univ Helsinki Licensing | Rypsin Agrobacterium-välitteinen transformaatio |
SG70124A1 (en) | 1997-09-26 | 2000-01-25 | Gen Electric | Method for making thermoplastic resin pellets |
US5994624A (en) | 1997-10-20 | 1999-11-30 | Cotton Incorporated | In planta method for the production of transgenic plants |
US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
US6043410A (en) | 1998-02-06 | 2000-03-28 | Calgene Llc | Strawberry fruit promoters for gene expression |
AUPP249298A0 (en) | 1998-03-20 | 1998-04-23 | Ag-Gene Australia Limited | Synthetic genes and genetic constructs comprising same I |
EP2267138B1 (en) | 1998-04-08 | 2016-06-08 | Commonwealth Scientific and Industrial Research Organization | Methods and means for obtaining modified phenotypes |
AR020078A1 (es) | 1998-05-26 | 2002-04-10 | Syngenta Participations Ag | Metodo para alterar la expresion de un gen objetivo en una celula de planta |
JP2000083680A (ja) | 1998-07-16 | 2000-03-28 | Nippon Paper Industries Co Ltd | 光誘導型プロモ―タ―の制御下に置かれた不定芽再分化遺伝子を選抜マ―カ―遺伝子とする植物への遺伝子導入方法及びこれに用いる植物への遺伝子導入用ベクタ― |
EP1117816B1 (en) | 1998-10-01 | 2005-12-21 | Pioneer Hi-Bred International, Inc. | Method of plant transformation |
US6825397B1 (en) * | 1998-11-09 | 2004-11-30 | Pioneer Hi-Bred International, Inc. | LEC1 trancriptional activator nucleic acids and methods of use thereof |
DK1135511T3 (da) * | 1998-11-17 | 2009-07-27 | Monsanto Technology Llc | Phosphonatmetaboliserende planter |
US6420630B1 (en) | 1998-12-01 | 2002-07-16 | Stine Biotechnology | Methods for tissue culturing and transforming elite inbreds of Zea mays L. |
US6846970B1 (en) | 1999-07-19 | 2005-01-25 | Plant Bioscience Limited | Transformation method and transgenic plants produced thereby |
US6603061B1 (en) | 1999-07-29 | 2003-08-05 | Monsanto Company | Agrobacterium-mediated plant transformation method |
EP1111063A1 (en) | 1999-12-24 | 2001-06-27 | Coöperatieve Verkoop- en Productievereniging van Aardappelmeel en Derivaten 'AVEBE' B.V. | Modified DHPS genes |
WO2001064023A1 (en) | 2000-03-02 | 2001-09-07 | Auburn University | Marker free transgenic plants: engineering the chloroplast genome without the use of antibiotic selection |
AU5369201A (en) | 2000-04-24 | 2001-11-07 | Vertex Pharma | Process and intermediates for making substituted aspartic acid acetals |
US6492174B1 (en) * | 2000-06-19 | 2002-12-10 | Institute Of Paper Science & Technology | Methods of initiating embryogenic cultures in plants |
AU8980001A (en) * | 2000-08-11 | 2002-02-25 | Syngenta Participations Ag | Methods for stable transformation of plants |
US6995016B2 (en) | 2000-08-17 | 2006-02-07 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food | Process for inducing direct somatic embryogenesis in immature scutella cells of pooideae, and rapidly regenerating fertile plants |
AUPR143100A0 (en) * | 2000-11-10 | 2000-12-07 | Bureau Of Sugar Experiment Stations | Plant transformation |
CN1356389A (zh) * | 2000-12-08 | 2002-07-03 | 大连理工大学 | 一种无选择标记的植物转基因方法 |
US7098383B2 (en) | 2000-12-19 | 2006-08-29 | Sembiosys Genetics Inc. | Methods for the production of multimeric immunoglobulins, and related compositions |
DE10101276A1 (de) | 2001-01-12 | 2002-07-18 | Icon Genetics Ag | Verfahren und Vektoren zur Transformation von Plastiden |
CA2451863A1 (en) * | 2001-06-15 | 2002-12-27 | The University Of Toledo | Method for transformation of mono- and di- cotyledonous plants using meristematic tissue and nodal callus from dycotiledonous plants |
US20030082580A1 (en) * | 2001-07-06 | 2003-05-01 | Dna Plant Technology Corporation | Plant cell culture and selection system |
US20030115641A1 (en) | 2001-07-24 | 2003-06-19 | Dobres Michael S. | Transformation of plants by electroporation of cultured explants |
JP2003047463A (ja) | 2001-07-24 | 2003-02-18 | Kumho Petrochem Co Ltd | シバ成熟種子由来カルスのための植物体再生方法 |
EP1279737A1 (en) | 2001-07-27 | 2003-01-29 | Coöperatieve Verkoop- en Productievereniging, van Aardappelmeel en Derivaten AVEBE B.A. | Transformation method for obtaining marker-free plants |
US20030135891A1 (en) | 2001-12-04 | 2003-07-17 | The Texas A&M University System | Method of transforming intact plants |
EP1585384B1 (en) * | 2002-02-20 | 2012-07-11 | J.R. Simplot Company | Precise breeding |
US20030196219A1 (en) | 2002-04-16 | 2003-10-16 | Monsanto Technology Llc | Novel Method for Agrobacterium Preparation for Plant Transformation |
WO2004022707A2 (en) * | 2002-09-03 | 2004-03-18 | The Regents Of The University Of California | Method and compositions for transformation and regeneration of maize |
JP2006508681A (ja) * | 2002-12-06 | 2006-03-16 | デル・モンテ・フレッシュ・プロデュース・カンパニー | カロテノイドレベルを改変したトランスジェニックパイナップル植物体及びその作製方法 |
US20040210961A1 (en) | 2003-03-07 | 2004-10-21 | Palys Joseph Michael | Markerless transformation |
US20040210958A1 (en) | 2003-03-19 | 2004-10-21 | Monsanto Technology Llc | A Novel Culture Method for Corn Transformation |
US20040210959A1 (en) | 2003-03-19 | 2004-10-21 | Monsanto Technology Llc | A Novel Method for Production of Transformed Dihaploid Corn Plants |
US7575917B2 (en) | 2003-04-09 | 2009-08-18 | Monsanto Technology Llc | DNA constructs and methods to enhance the production of commercially viable transgenic plants |
US7682829B2 (en) * | 2003-05-30 | 2010-03-23 | Monsanto Technology Llc | Methods for corn transformation |
BRPI0411479A (pt) | 2003-06-17 | 2006-07-25 | Sembiosys Genetics Inc | métodos para a produção de insulina em plantas |
US7560611B2 (en) | 2003-08-05 | 2009-07-14 | Monsanto Technology Llc | Method and apparatus for substantially isolating plant tissues |
US7150993B2 (en) | 2003-08-05 | 2006-12-19 | Monsanto Technology Llc | Method for excision of plant embryos for transformation |
TW200526778A (en) | 2003-11-14 | 2005-08-16 | Sembiosys Genetics Inc | Methods for the production of apolipoproteins in transgenic plants |
US7897838B2 (en) | 2004-04-20 | 2011-03-01 | Temasek Life Sciences Laboratory Limited | Methods for high efficiency transformation and regeneration of plant suspension cultures |
US7572635B2 (en) * | 2004-06-25 | 2009-08-11 | Monsanto Technology Llc | Method for agrobacterium transformation for dihaploid corn plants |
US8124411B2 (en) | 2006-08-31 | 2012-02-28 | Monsanto Technology Llc | Methods for producing transgenic plants |
US8058514B2 (en) | 2007-02-28 | 2011-11-15 | Japan Tobacco Inc. | Agrobacterium-mediated method for producing transformed plant without selection step |
EP3515063A1 (en) | 2007-04-02 | 2019-07-24 | Esight Corp. | A method for augmenting sight |
WO2009029852A2 (en) | 2007-08-31 | 2009-03-05 | Monsanto Technology Llc | Method and apparatus for substantially isolating plant tissues |
MY145205A (en) | 2007-12-28 | 2012-01-13 | Mimos Berhad | Vibratory sensor |
JP2011120478A (ja) | 2008-03-31 | 2011-06-23 | Japan Tobacco Inc | アグロバクテリウム菌による形質転換植物の作成方法 |
EP2110528B2 (en) | 2008-04-18 | 2017-04-19 | Daimler AG | Apparatus for treating an exhaust gas stream with removable module |
JP5615539B2 (ja) * | 2009-12-08 | 2014-10-29 | 株式会社タイヨー製作所 | 連続式加熱処理方法及び連続式加熱処理装置 |
US20110162112A1 (en) * | 2009-12-31 | 2011-06-30 | Pioneer Hi-Bred International, Inc. | Increasing time-efficiency of high-throughput transformation processes |
-
2007
- 2007-08-31 US US11/848,554 patent/US8124411B2/en active Active
- 2007-08-31 MX MX2009002250A patent/MX2009002250A/es active IP Right Grant
- 2007-08-31 JP JP2009526931A patent/JP5329412B2/ja active Active
- 2007-08-31 US US11/848,579 patent/US8581035B2/en active Active
- 2007-08-31 BR BRPI0716373-8A patent/BRPI0716373B1/pt active IP Right Grant
- 2007-08-31 DE DE602007012269T patent/DE602007012269D1/de active Active
- 2007-08-31 AU AU2007289105A patent/AU2007289105B2/en active Active
- 2007-08-31 WO PCT/US2007/077366 patent/WO2008028119A2/en active Application Filing
- 2007-08-31 CA CA2884046A patent/CA2884046C/en active Active
- 2007-08-31 EP EP07841704.5A patent/EP2054517B1/en active Active
- 2007-08-31 CA CA2917034A patent/CA2917034C/en active Active
- 2007-08-31 BR BR122017012510-9A patent/BR122017012510B1/pt active IP Right Grant
- 2007-08-31 US US11/848,648 patent/US8395020B2/en active Active
- 2007-08-31 JP JP2009526930A patent/JP5242570B2/ja active Active
- 2007-08-31 MX MX2009002252A patent/MX2009002252A/es active IP Right Grant
- 2007-08-31 MX MX2009002248A patent/MX2009002248A/es active IP Right Grant
- 2007-08-31 CN CN200780040000.2A patent/CN101528933B/zh active Active
- 2007-08-31 CA CA3066436A patent/CA3066436C/en active Active
- 2007-08-31 EP EP11174892.7A patent/EP2390337B1/en active Active
- 2007-08-31 AU AU2007289109A patent/AU2007289109B2/en active Active
- 2007-08-31 AT AT07814616T patent/ATE497008T1/de not_active IP Right Cessation
- 2007-08-31 CN CN201410643281.2A patent/CN104357535B/zh active Active
- 2007-08-31 EP EP07814616A patent/EP2057272B1/en active Active
- 2007-08-31 CN CN2007800400731A patent/CN101528934B/zh active Active
- 2007-08-31 JP JP2009526926A patent/JP5350246B2/ja active Active
- 2007-08-31 CA CA2884022A patent/CA2884022C/en active Active
- 2007-08-31 CN CN200780039999.9A patent/CN101528932B/zh active Active
- 2007-08-31 CA CA2666821A patent/CA2666821C/en active Active
- 2007-08-31 EP EP07814620.6A patent/EP2069510B1/en active Active
- 2007-08-31 CN CN201410460695.1A patent/CN104232680B/zh active Active
- 2007-08-31 BR BRPI0716225-1A patent/BRPI0716225B1/pt active IP Right Grant
- 2007-08-31 CA CA2661825A patent/CA2661825C/en active Active
- 2007-08-31 CA CA2973552A patent/CA2973552C/en active Active
- 2007-08-31 CA CA2661181A patent/CA2661181C/en active Active
- 2007-08-31 AU AU2007289111A patent/AU2007289111B2/en not_active Ceased
- 2007-08-31 BR BRPI0716207A patent/BRPI0716207B1/pt not_active IP Right Cessation
- 2007-08-31 EP EP17188292.1A patent/EP3269818A1/en not_active Ceased
- 2007-08-31 WO PCT/US2007/077361 patent/WO2008028115A2/en active Application Filing
- 2007-08-31 WO PCT/US2007/077370 patent/WO2008028121A1/en active Application Filing
-
2009
- 2009-02-17 ZA ZA2009/01140A patent/ZA200901140B/en unknown
- 2009-02-18 ZA ZA2009/01174A patent/ZA200901174B/en unknown
- 2009-02-26 ZA ZA2009/01405A patent/ZA200901405B/en unknown
-
2012
- 2012-01-20 US US13/355,312 patent/US8513016B2/en active Active
-
2013
- 2013-03-08 US US13/791,186 patent/US8853488B2/en active Active
- 2013-07-18 US US13/945,727 patent/US8962326B2/en active Active
- 2013-08-22 US US13/973,243 patent/US8847009B2/en active Active
-
2014
- 2014-09-11 US US14/483,748 patent/US9783813B2/en active Active
- 2014-09-23 US US14/494,495 patent/US9617552B2/en active Active
-
2015
- 2015-01-16 US US14/598,744 patent/US10006036B2/en active Active
-
2017
- 2017-03-20 US US15/464,287 patent/US10233455B2/en active Active
- 2017-09-29 US US15/720,759 patent/US20180119157A1/en not_active Abandoned
-
2018
- 2018-05-11 US US15/977,265 patent/US11091766B2/en active Active
-
2019
- 2019-01-29 US US16/261,083 patent/US10941407B2/en active Active
-
2020
- 2020-12-18 US US17/127,357 patent/US20210171964A1/en not_active Abandoned
-
2021
- 2021-07-08 US US17/370,598 patent/US11718855B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2069510B1 (en) | Methods for rapidly transforming monocots | |
US10253322B2 (en) | Method for the production of transgenic plants | |
Retheesh et al. | Genetic transformation and regeneration of transgenic plants from protocorm-like bodies of vanilla (Vanilla planifolia Andrews) using Agrobacterium tumefaciens | |
US11807846B2 (en) | Methods for transforming corn explants | |
US9284567B2 (en) | Method for gene introduction into hordeum plant using agrobacterium, and method for production of transformed plant of hordeum plant | |
US20040210958A1 (en) | A Novel Culture Method for Corn Transformation | |
US20240301435A1 (en) | Compositions and methods for transformation of monocot seed excised embryo explants | |
WO2016104583A1 (ja) | アグロバクテリウム菌を用いた、ソルガム属植物への遺伝子導入方法およびソルガム属植物の形質転換植物の作成方法 | |
WO2023049894A1 (en) | Compositions and methods for transformation of monocot seed excised embryo explants | |
WO2023049898A1 (en) | Compositions and methods for transformation of monocot seed excised embryo explants |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20090225 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA HR MK RS |
|
17Q | First examination report despatched |
Effective date: 20090731 |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 623510 Country of ref document: AT Kind code of ref document: T Effective date: 20130815 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602007031887 Country of ref document: DE Effective date: 20130919 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 623510 Country of ref document: AT Kind code of ref document: T Effective date: 20130724 |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131124 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130731 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131125 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20131025 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130831 Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130831 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed |
Effective date: 20140425 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130831 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602007031887 Country of ref document: DE Effective date: 20140425 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: MT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20130724 Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130831 Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20070831 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20240725 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20240717 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20240718 Year of fee payment: 18 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20240726 Year of fee payment: 18 |